| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |